We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Proteomic Profiles Associated With Postsurgical Progression in Nonfunctioning Pituitary Adenomas.
- Authors
Hallén, Tobias; Johannsson, Gudmundur; Thorsell, Annika; Olsson, Daniel S; Örndal, Charlotte; Engvall, Angelica; Jacobson, Frida; Widgren, Anna; Bergquist, Jonas; Skoglund, Thomas
- Abstract
Context There is a lack of reliable biomarkers capable of predicting postoperative tumor progression of nonfunctioning pituitary adenomas (NFPAs). Objective To discover proteomic profiles associated with postoperative tumor progression in patients with NFPAs. This was a case-controlled exploratory study at a tertiary university hospital. Tissue samples were obtained from 46 patients with residual tumor following surgery for NFPAs of gonadotroph lineage. Two patient groups were compared: patients requiring reintervention due to residual tumor progression (cases; reintervention group, n = 29) and patients with a residual tumor showing no progression for a minimum of 5 years (controls; radiologically stable group, n = 17). Differentially expressed proteins (DEPs) between patient groups were measured. Results Global quantitative proteomic analysis identified 4074 proteins, of which 550 were differentially expressed between the 2 groups (fold change >80%, false discovery rate–adjusted P ≤.05). Principal component analysis showed good separation between the 2 groups. Functional enrichment analysis of the DEPs indicated processes involving translation, ROBO-receptor signaling, energy metabolism, mRNA metabolism, and RNA splicing. Several upregulated proteins in the reintervention group, including SNRPD1, SRSF10, SWAP-70, and PSMB1, are associated with tumor progression in other cancer types. Conclusion This is the first exploratory study analyzing proteomic profiles as markers of postoperative tumor progression in NFPAs. The findings clearly showed different profiles between tumors with indolent postoperative behavior and those with postoperative tumor progression. Both enriched pathways involving DEPs and specific upregulated proteins have previously been associated with tumor aggressiveness. These results suggest the value of proteomic profiling for predicting tumor progression in patients with NFPAs.
- Subjects
RNA metabolism; PITUITARY tumors; PROTEOMICS; RNA splicing; CANCER invasiveness; PRINCIPAL components analysis
- Publication
Journal of Clinical Endocrinology & Metabolism, 2024, Vol 109, Issue 6, p1485
- ISSN
0021-972X
- Publication type
Article
- DOI
10.1210/clinem/dgad767